Neumora Therapeutics (NASDAQ:NMRA) Shares Down 3

Dec 24, 2024 · Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report)'s share price fell 3% during mid-day trading on Tuesday . The stock traded as low as $10.58 and last traded at …

3%
OFF

Neumora Therapeutics (NASDAQ:NMRA) Shares Down 3

2 weeks from now

Dec 24, 2024 · Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report)'s share price fell 3% during mid-day trading on Tuesday . The stock traded as low as $10.58 and last traded at …

marketbeat.com

3%
OFF

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Down 3% – …

2 weeks from now

Dec 26, 2024 · Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) dropped 3% during mid-day trading on Tuesday .The company traded as low as $10.58 and last traded at …

etfdailynews.com

3%
OFF

Neumora Therapeutics (NASDAQ:NMRA) Trading Down 3% – …

2 weeks from now

Dec 26, 2024 · Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) dropped 3% on Tuesday . The stock traded as low as $10.58 and last traded at $10.79. …

americanbankingnews.com

3%
OFF

Neumora Therapeutics (NASDAQ:NMRA) Trading Down 4.3

2 weeks from now

Dec 31, 2024 · Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA - Get Free Report) dropped 4.3% on Tuesday . The stock traded as low as $10.48 and last traded at $10.58. …

marketbeat.com

80%
OFF

Neumora Shares Plunge As Navacaprant Misses Key Endpoints In …

2 weeks from now

Jan 2, 2025 · (RTTNews) - Shares of Neumora Therapeutics, Inc. (NMRA) are down more than 80% at $1.81 in premarket trading Thursday, following the release of topline results from its …

nasdaq.com

80%
OFF

Neumora Shares Slump After Depression Drug Fails In Key Trial

2 weeks from now

Jan 2, 2025 · Neumora Therapeutics' shares tumbled more than 80% on Thursday after its experimental depression drug failed to reduce symptoms such as sadness and pessimistic …

reuters.com

80%
OFF

Neumora Therapeutics Stock Tanks As Its Depression Drug Misses …

2 weeks from now

Jan 2, 2025 · Neumora Therapeutics shares crashed 80% to an all-time low Thursday when the biopharmaceutical firm announced that a late-stage study of its experimental treatment for …

investopedia.com

$7.00
OFF

Neumora Stock Faces Skepticism After Failed Trial, But BofA Remains ...

2 weeks from now

Jan 6, 2025 · On Monday, BofA Securities announced a significant reduction in the price target for Neumora Therapeutics (NASDAQ:NMRA) shares, adjusting it to $7.00 from the previous …

investing.com

80%
OFF

Neumora Shares Look Oversold After 80% Drop, Says Mizuho

2 weeks from now

Jan 3, 2025 · Mizuho keeps an Outperform rating on Neumora Therapeutics (NMRA) after the company announced negative first Phase 3 KOASTAL-1/K-1 study data for navacaprant in …

nasdaq.com

80%
OFF

Neumora Plummets On Depression Drug Data | BioPharma Dive

2 weeks from now

Jan 2, 2025 · Shares of Neumora Therapeutics fell more than 80% on Jan. 2, 2025, after the company's lead drug failed a Phase 3 study in depression. image_jungle via Getty Images …

biopharmadive.com

$15
OFF

Neumora Therapeutics Downgraded To Neutral From Overweight …

2 weeks from now

Oct 2, 2024 · JPMorgan analyst Tessa Romero downgraded Neumora Therapeutics (NMRA) to Neutral from Overweight with a price target of $15, down from $18. Results from the Phase 3 …

nasdaq.com

$8.63
OFF

Neumora Therapeutics' (NMRA) Buy Rating Reaffirmed At

2 weeks from now

Jan 2, 2025 · Shares of NASDAQ NMRA traded down $8.63 during mid-day trading on Thursday, reaching $1.97. The company had a trading volume of 44,511,355 shares, compared to its …

marketbeat.com

$175000
OFF

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average

2 weeks from now

Jan 2, 2025 · Finally, Intech Investment Management LLC purchased a new stake in shares of Neumora Therapeutics during the 3rd quarter valued at about $175,000. Institutional investors …

marketbeat.com

$2.28
OFF

Neumora Therapeutics' (NMRA) Outperform Rating Reiterated

2 weeks from now

1 day ago · Get Our Latest Stock Report on Neumora Therapeutics Neumora Therapeutics Stock Performance. Shares of Neumora Therapeutics stock opened at $2.28 on Wednesday. The …

marketbeat.com

FAQs about Neumora Therapeutics (NASDAQ:NMRA) Shares Down 3 Coupon?

Did neumora Therapeutics (NMRA) drop 3% during mid-day trading?

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) dropped 3% during mid-day trading on Tuesday . The company traded as low as $10.58 and last traded at $10.79. Approximately 68,888 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 748,016 shares. The stock had previously closed at $11.12. ...

What was neumora Therapeutics' stock price on January 1st 2025?

Neumora Therapeutics' stock was trading at $10.60 on January 1st, 2025. Since then, NMRA stock has decreased by 79.5% and is now trading at $2.17. How were Neumora Therapeutics' earnings last quarter? Neumora Therapeutics, Inc. (NASDAQ:NMRA) posted its quarterly earnings data on Tuesday, November, 12th. ...

Is neumora Therapeutics a good stock to buy?

One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Neumora Therapeutics has a consensus rating of “Moderate Buy” and an average target price of $23.40. Want More Great Investing Ideas? 10 Stocks to Sell NOW! ...

How much is neumora Therapeutics (NMRA) worth?

The company has a market cap of $1.72 billion, a P/E ratio of -5.68 and a beta of 3.34. The company has a 50 day moving average price of $11.29 and a 200-day moving average price of $11.56. Neumora Therapeutics (NASDAQ:NMRA – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. ...

Who owns neumora Therapeutics?

The Manufacturers Life Insurance Company lifted its holdings in shares of Neumora Therapeutics by 79.5% during the second quarter. The Manufacturers Life Insurance Company now owns 111,828 shares of the company’s stock worth $1,099,000 after purchasing an additional 49,527 shares during the period. ...

When did neumora Therapeutics IPO?

Neumora Therapeutics (NMRA) raised $250 million in an IPO on Friday, September 15th 2023. The company issued 14,710,000 shares at $17.00 per share. How do I buy shares of Neumora Therapeutics? Shares of NMRA stock can be purchased through any online brokerage account. ...